Gene activity study in kidney transplant patients
Part of Kidney & urinary clinical trials.
This study looks at gene activity inside kidney tissue to better understand how transplanted kidneys work. Researchers will collect blood, urine, stool, and tiny pieces of kidney tissue over time to see what happens after a transplant.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must be able to give consent (an interpreter can help).
- You agree to be followed over time (you can quit later).
- You agree to give extra samples for research—like blood, urine, stool, or kidney tissue.
- You are not expected to live less than 6 months.
- You have not had a stem cell transplant in the last 5 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at how genes affect kidney transplant outcomes. It asks you to give extra blood, urine, stool, and kidney tissue samples over time, so researchers can learn more about why some transplants work better than others.
This study collects health and genetic information from children who have had a liver or kidney transplant, to better understand their long-term health. It aims to improve care while protecting patient privacy.
This study looks at how genes affect long-term kidney transplant health. It aims to understand why some transplanted kidneys fail over time, and may help personalize care for transplant recipients.
This study looks at how genes affect kidney disease in people from diverse backgrounds. It may help researchers understand why some people get kidney disease and others don't, which could lead to better prevention and treatment.
This study follows people who are getting a kidney transplant (first or later) to better understand how the body recovers, using health tracking and “gene/protein” (proteogenomic) information. It may help doctors predict complications and improve care after transplant.
This study checks samples from people after a kidney transplant to better understand how treatment is working at a biological (molecular) level. It may help doctors improve follow-up care and therapy over time.
Hear when a new Transplant Complication trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.